STOCK TITAN

IRIDEX CFO buys 2,354 shares at $0.65

IRIDEX’s chief financial officer increased his personal IRIX shareholdings through a small open-market purchase.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IRIDEX CORP (IRIX) reported that its Chief Financial Officer, Romeo R. Dizon, purchased 2,354 shares of common stock on September 14, 2026 at $0.65 per share in an open-market or private transaction. Following this buy, he directly holds 177,406 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Positive

  • None.

Negative

  • None.
Insider Dizon Romeo R
Role Chief Financial Officer
Bought 2,354 shs ($2K)
Type Security Shares Price Value
Purchase Common Stock 2,354 $0.65 $2K
Holdings After Transaction: Common Stock — 177,406 shares (Direct)
Shares purchased 2,354 shares Common stock bought by the CFO on September 14, 2026
Purchase price per share $0.65 per share Price paid by the CFO for IRIDEX common stock
Shares owned after transaction 177,406 shares Direct holdings of the CFO following the reported purchase
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for this transaction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market market
"Purchase in open market or private transaction"
Open-market describes trading that happens in a public marketplace where many buyers and sellers can freely buy and sell securities or assets, like stocks or bonds, rather than through a private agreement. It matters to investors because prices in an open market reflect real-time supply and demand, making it easier to buy or sell quickly and to gauge fair market value — like checking a public price board instead of negotiating one-on-one.
Form 4 regulatory
"The Form 4 for IRIDEX CORP shows a purchase"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IRIX report for its CFO?

IRIDEX CORP reported that Chief Financial Officer Romeo R. Dizon bought 2,354 shares of common stock on September 14, 2026 in an open-market or private transaction at $0.65 per share.

How many IRIX shares does the CFO own after this reported trade?

After the reported purchase, IRIDEX CORP’s CFO Romeo R. Dizon directly owns 177,406 shares of the company’s common stock.

Was the IRIX CFO’s September 14, 2026 trade under a Rule 10b5-1 plan?

No. The filing indicates no Rule 10b5-1 trading plan for the September 14, 2026 purchase by IRIDEX CORP’s Chief Financial Officer.

What price did the IRIX CFO pay per share in the latest Form 4?

In the Form 4, IRIDEX CORP’s CFO is reported to have paid $0.65 per share for 2,354 shares of the company’s common stock on September 14, 2026.

Was the IRIX CFO’s Form 4 transaction a purchase or a sale?

The Form 4 for IRIDEX CORP shows a purchase by the Chief Financial Officer, involving 2,354 shares of common stock at $0.65 per share on September 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dizon Romeo R

(Last)(First)(Middle)
1212 TERRA BELLA AVENUE

(Street)
MOUNTAIN VIEW CALIFORNIA 94043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/14/2026P2,354A$0.65177,406D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading